Published in World J Gastroenterol on April 28, 2011
Update on Autoimmune Hepatitis. J Clin Transl Hepatol (2015) 0.89
Liver transplantation and autoimmune hepatitis. Intractable Rare Dis Res (2015) 0.75
Severe viral oesophagitis, pharyngitis, and stomatitis as antecedents of ileocecal Crohn's disease. Prz Gastroenterol (2015) 0.75
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43
Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology (2008) 6.35
Acute liver failure: redefining the syndromes. Lancet (1993) 4.99
Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology (1972) 4.29
Acute liver failure: Summary of a workshop. Hepatology (2008) 3.49
Acute liver failure. Lancet (2010) 3.39
Diagnosis and treatment of autoimmune hepatitis. Hepatology (2002) 3.13
Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet (1973) 2.98
Autoimmune hepatitis in childhood: a 20-year experience. Hepatology (1997) 1.97
Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology (2005) 1.89
The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology (2007) 1.78
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology (2002) 1.77
Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology (2009) 1.77
Acute liver failure in Spain: analysis of 267 cases. Liver Transpl (2007) 1.71
Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation-12 years experience in the nordic countries. Liver Transpl (2002) 1.58
Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis. Mayo Clin Proc (1990) 1.56
Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol (2004) 1.48
Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology (1993) 1.41
Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl (2007) 1.31
Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology (1996) 1.29
Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol (1991) 1.21
Liver transplantation for autoimmune hepatitis. Hepatology (2000) 1.16
Late onset hepatic failure: clinical, serological and histological features. Hepatology (1986) 1.06
Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases. Aliment Pharmacol Ther (2006) 1.00
Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy. Am J Gastroenterol (2004) 0.98
Subfulminant hepatic failure in autoimmune hepatitis type 1: an unusual form of presentation. J Hepatol (1997) 0.96
Predictors of bacteraemia and mortality in patients with acute liver failure. Intensive Care Med (2009) 0.96
Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. QJM (2004) 0.96
Prospective study comparing the efficacy of prophylactic parenteral antimicrobials, with or without enteral decontamination, in patients with acute liver failure. Liver Transpl Surg (1996) 0.93
Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features. Clin Liver Dis (2002) 0.92
Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis. Am J Gastroenterol (2002) 0.92
Etiology and outcome of fulminant hepatic failure managed at an Australian liver transplant unit. J Gastroenterol Hepatol (2004) 0.90
Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology (2007) 0.89
The nature and prognostic implications of autoimmune hepatitis with an acute presentation. J Hepatol (1994) 0.89
Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry. Liver Transpl (2010) 0.85
Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease. Hepatology (1995) 0.85
Steroid therapy in fulminant hepatic failure secondary to autoimmune hepatitis. P R Health Sci J (1998) 0.85
Vincristine potentiates cytochalasin B-induced DNA fragmentation in vitro. Cancer Chemother Pharmacol (1992) 0.85
Liver failure as initial presentation of autoimmune hepatitis: clinical characteristics, predictors of response to steroid therapy, and outcomes. Hepatology (2009) 0.84
Liver transplantation for autoimmune hepatitis: a 12-year experience. Transplant Proc (1997) 0.77
In type 1 autoimmune hepatitis, is cirrhosis at presentation or follow-up associated with a poorer outcome? Hepatology (2005) 0.76
Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology (2002) 2.25
Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology (2002) 1.98
Gastrointestinal stromal tumors: clinical profile, pathogenesis, treatment strategies and prognosis. J Gastroenterol Hepatol (2005) 1.76
Hepatitis E infection is an under recognized cause of acute decompensation in patients with chronic liver disease. Dig Liver Dis (2012) 1.49
Animal interactions and the emergence of territoriality. PLoS Comput Biol (2011) 1.49
Autoimmune hepatitis. Lancet (2013) 1.09
Hepatotoxicity associated with dietary supplements containing anabolic steroids. Clin Gastroenterol Hepatol (2007) 0.91
Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from ATP8B1/ABCB11 mutations? Liver Int (2013) 0.89
Accumulation of (18)F-FDG in the liver in hepatic steatosis. AJR Am J Roentgenol (2014) 0.89
Stigmergy, collective actions, and animal social spacing. Proc Natl Acad Sci U S A (2013) 0.87
Liver failure as initial presentation of autoimmune hepatitis: clinical characteristics, predictors of response to steroid therapy, and outcomes. Hepatology (2009) 0.84
Alcoholic hepatitis: diagnosis and management in 2012. Expert Rev Gastroenterol Hepatol (2012) 0.79
Recurrent severe alcoholic hepatitis: clinical characteristics and outcomes. Eur J Gastroenterol Hepatol (2013) 0.79
Accuracy and reliability of the endoscopic classification of portal hypertensive gastropathy. Gastrointest Endosc (2002) 0.78
Isolated hepatic metastasis from a gastrointestinal stromal tumor (GIST) 17 years after initial resection: need for long-term surveillance. J Clin Gastroenterol (2005) 0.78
Gender differences in hepatitis C seroprevalence and suboptimal vaccination and hepatology services uptake amongst substance misusers. J Med Virol (2012) 0.77
In type 1 autoimmune hepatitis, is cirrhosis at presentation or follow-up associated with a poorer outcome? Hepatology (2005) 0.76
Long-term outcomes after hospitalization with spontaneous bacterial peritonitis. J Dig Dis (2015) 0.76
In type 1 autoimmune hepatitis (AIH), should remission be redefined as normalization of transaminases? J Hepatol (2006) 0.75
Correlation between hepatitis B virus DNA levels and liver histology: is the controversy because of paucity of data? J Clin Gastroenterol (2007) 0.75
Correction for Giuggioli et al., Stigmergy, collective actions, and animal social spacing. Proc Natl Acad Sci U S A (2016) 0.75
Occult hepatic opportunistic infection (OI) and highly active antiretroviral therapy (HAART) induced immune reconstitution: an important cause of jaundice in a patient with AIDS. AIDS Res Hum Retroviruses (2006) 0.75
Spatial Patterning of Prey at Reproduction to Reduce Predation Risk: What Drives Dispersion from Groups? Am Nat (2016) 0.75
A Dedicated Hostel-based Liver Service for Vulnerable/Homeless Adults: Response to: Needs Assessment of HCV-Infected Individuals Experiencing Homelessness and Implications. J Health Care Poor Underserved (2017) 0.75